Healthcare Global Enterprises Ltd
Healthcare Global Enterprises Q2 FY26: Revenue ₹4,000 Cr
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Overall revenue growth expected to outpace industry, sustaining over 15% per annum. Revenue growth expected at 15%+ CAGR over medium to long term, outpacing industry growth.
From Healthcare Global Enterprises Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Overall revenue growth expected to outpace industry, sustaining over 15% per annum.
- Average realization improvement targeted at 4% to 5% annually.
- Inpatient volume growth anticipated at 9% to 10% in near to midterm.
- Incremental revenue growth split: 70%-75% from existing centres, 10%-15% from brownfield expansion, and 8%-10% from greenfield projects.
- Existing network has significant growth potential through capacity expansion, addition of clinical teams, specialty mix enhancement, and technology upgrades.
- Medium-term goal to realize Rs.4,000 crore revenue potential over 4-5 years from current Rs.2,200 crore at existing price points and optimized utilization.
2 more points from Healthcare Global Enterprises Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Healthcare Global Enterprises Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Next 2-3 years planned capex: Rs. 600-700 crore
- Rs. 300 crore dedicated to maintenance capex
- Remaining for upgrading infrastructure, increasing existing capacity, and brownfield expansion
- Brownfield expansion to add around 700 beds in markets like Ahmedabad, Vizag, Baroda, Cuttack
- Greenfield expansion planned in 10-12 new cities (e.g., Pune, Surat, Varanasi, Kanpur), adding 200-400 beds
- Greenfield projects largely funded through internal accruals, maintaining net debt to EBITDA ratio of 2-2.5x
2 more points from Healthcare Global Enterprises Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Healthcare Global Enterprises Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Healthcare Global Enterprises Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Healthcare Global Enterprises Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹652 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Healthcare Global Enterprises Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
Others in Healthcare Services this season
- Maitreya Medica. (Q2 FY26)
23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medica.'s Q2 FY26 investor presentation — and how it ranks against sector peers.
- Metropolis Healt (Q2 FY26)
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
- 3B Blackbio (Q2 FY26)
Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…
- Unihealth Hosp (Q2 FY26)
Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India). Key concall takeaways from Unihealth Hospitals Ltd's Q2 FY26…
Arthneeti Pro · Annual
Healthcare Global Enterprises Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Healthcare Global Enterprises Ltd Q2 FY26 results?
Overall revenue growth expected to outpace industry, sustaining over 15% per annum. Revenue growth expected at 15%+ CAGR over medium to long term, outpacing industry growth.
What is Healthcare Global Enterprises Ltd share price analysis?
Healthcare Global Enterprises Ltd currently shows a neutral. The stock trades at a P/E of 221.3 with a market cap of ₹10,665 Cr. Investors should review the full earnings analysis for detailed insights.
Is Healthcare Global Enterprises Ltd planning capital expenditure?
Next 2-3 years planned capex: Rs.
Keep Healthcare Global Enterprises Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.